Bit Capital Gmb H Replimune Group, Inc. Transaction History

Bit Capital Gmb H

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2025	SELL	$6.75 - $16.18 $39,906 - $95,656	-5,912 Closed	0 $0
Q3 2023 Feb 12, 2025	SELL	$15.96 - $22.18 $20,125 - $27,968	-1,261 Reduced 17.58%	5,912 $101 Million
Q2 2023 Feb 12, 2025	SELL	$15.65 - $24.1 $276,300 - $425,485	-17,655 Reduced 71.11%	7,173 $167 Million
Q1 2023 Feb 12, 2025	BUY	$17.48 - $29.09 $360,577 - $600,068	20,628 Added 491.14%	24,828 $438 Million
Q4 2022 Feb 12, 2025	BUY	$17.09 - $27.91 $71,778 - $117,222	4,200 New	4,200 $114 Million

152

68.3M

52.3K

80.3K

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $634M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

Get notified when there are updates to the investment portfolio of Bit Capital Gmb H, based on Form 13F filings with the SEC.

Stay updated on Bit Capital Gmb H with notifications on news.